FeaturedNeurologyNeuroscience·March 9, 2023·6 min readInvestigational Anti-amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory LossSolanezumab, an investigational anti-amyloid treatment, does not significantly slow the cognitive decline associated with Alzheimer's disease.Read More
FeaturedGeneticsNeurologyNeuroscience·June 21, 2021·5 min readInvestigational Alzheimer’s Drug Improves Biomarkers of the DiseaseGantenerumab, an investigational drug for Alzheimer's disease, reduced amyloid plaques and lowered tau levels in the brains of people with genetic risk factors for the neurodegenerative disorder.Read More
FeaturedGeneticsNeurologyNeuroscience·April 6, 2020·4 min readAlzheimer’s trial screening data links high amyloid levels with early stage diseaseFindings support the hypothesis that higher levels of amyloid in the brain is an indicator of the early stages of Alzheimer's disease.Read More
FeaturedNeurology·July 23, 2015·2 min readNew Drug Slows Progression of Mild Alzheimer’s DiseaseA drug currently in phase 3 of trials appears to slow the progression of mild Alzheimer's disease.Read More
